Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Proto Labs (PRLB) Operating Leases (2019 - 2025)

Historic Operating Leases for Proto Labs (PRLB) over the last 7 years, with Q3 2025 value amounting to $1.2 million.

  • Proto Labs' Operating Leases fell 3996.97% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 3996.97%. This contributed to the annual value of $1.6 million for FY2024, which is 6444.59% down from last year.
  • Proto Labs' Operating Leases amounted to $1.2 million in Q3 2025, which was down 3996.97% from $1.4 million recorded in Q2 2025.
  • Proto Labs' 5-year Operating Leases high stood at $11.5 million for Q1 2021, and its period low was $1.2 million during Q3 2025.
  • Moreover, its 5-year median value for Operating Leases was $2.2 million (2024), whereas its average is $3.0 million.
  • Over the last 5 years, Proto Labs' Operating Leases had its largest YoY gain of 6997.77% in 2022, and its largest YoY loss of 7820.36% in 2022.
  • Proto Labs' Operating Leases (Quarter) stood at $2.2 million in 2021, then skyrocketed by 69.98% to $3.8 million in 2022, then grew by 20.36% to $4.6 million in 2023, then tumbled by 64.45% to $1.6 million in 2024, then dropped by 27.25% to $1.2 million in 2025.
  • Its Operating Leases was $1.2 million in Q3 2025, compared to $1.4 million in Q2 2025 and $1.5 million in Q1 2025.